pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

750 catalysts · 3,045 8k filing · 571 earnings · 249 grant · 179 approval · 172 phase 2 completion · 133 drug shortage

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 16 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 20 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 8 catalysts2026-11-03: 17 catalysts2026-11-04: 22 catalysts2026-11-05: 36 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: earnings×type: approval×from 2026-04-02×clear all
type
  • 8k filing3,045
  • earnings571
  • grant249
  • approval179
  • phase 2 completion172
  • drug shortage133
device 510k
116
  • phase 1 completion73
  • phase 2 initiation62
  • device pma59
  • therapy area

    no tagged catalysts yet

    Week of Mar 30, 2026

    16
    ›Apr 2, 2026approval131d agoNINTEDANIB ESYLATE — FDA approvalBoehringer Ingelheim Corp

    Sponsor: DR REDDYS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 2, 2026approval131d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

    Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL

    full page →ACETAZOLAMIDE →fda approvals ↗
    ›Apr 2, 2026approval131d agoNINTEDANIB ESYLATE — FDA approvalOfev

    Sponsor: SANDOZ. Form: CAPSULE. Route: ORAL

    full page →Ofev →fda approvals ↗
    ›Apr 2, 2026approval131d agoEYLEA HD (AFLIBERCEPT) — FDA approvalEYLEA HD

    Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION

    full page →EYLEA HD →fda approvals ↗
    ›Apr 2, 2026approval131d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

    Sponsor: ALKEM LABS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 2, 2026approval131d agoPALIPERIDONE — FDA approvalEskayef Pharmaceuticals Ltd

    Sponsor: ACTAVIS LABS FL INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 2, 2026approval131d agoNINTEDANIB ESYLATE — FDA approvalOfev

    Sponsor: CIPLA. Form: CAPSULE. Route: ORAL

    full page →Ofev →fda approvals ↗
    ›Apr 2, 2026approval131d agoGABAPENTIN — FDA approvalGABAPENTIN

    Sponsor: STRIDES PHARMA. Form: CAPSULE. Route: ORAL

    full page →GABAPENTIN →fda approvals ↗
    ›Apr 2, 2026approval131d agoNINTEDANIB ESYLATE — FDA approvalOfev

    Sponsor: DEXCEL. Form: CAPSULE. Route: ORAL

    full page →Ofev →fda approvals ↗
    ›Apr 2, 2026approval131d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

    Sponsor: NOVITIUM PHARMA. Form: TABLET. Route: ORAL

    full page →ACETAZOLAMIDE →fda approvals ↗
    ›Apr 2, 2026approval131d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

    Sponsor: MANKIND PHARMA. Form: TABLET. Route: ORAL

    full page →ACETAZOLAMIDE →fda approvals ↗
    ›Apr 2, 2026approval131d agoNINTEDANIB ESYLATE — FDA approvalOfev

    Sponsor: APOTEX. Form: CAPSULE. Route: ORAL

    full page →Ofev →fda approvals ↗
    ›Apr 3, 2026approval130d agoGLYCOPYRRONIUM TOSYLATE — FDA approvalJourney Medical Corp

    Sponsor: PADAGIS US. Form: CLOTH. Route: TOPICAL

    full page →fda approvals ↗
    ›Apr 3, 2026approval130d agoPHENYLEPHRINE HYDROCHLORIDE — FDA approvalPHENYLEPHRINE HYDROCHLORIDE

    Sponsor: BAXTER HLTHCARE CORP. Form: SOLUTION. Route: INTRAVENOUS

    full page →PHENYLEPHRINE HYDROCHLORIDE →fda approvals ↗
    ›Apr 3, 2026approval130d agoTYVASO (TREPROSTINIL) — FDA approvalUNITED THERAPEUTICS Corp

    Sponsor: UNITED THERAP. Form: SOLUTION. Route: INHALATION

    full page →fda approvals ↗
    ›Apr 3, 2026approval130d agoONDANSETRON HYDROCHLORIDE — FDA approvalRedHill Biopharma Ltd.

    Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗

    Week of Apr 6, 2026

    34
    ›Apr 6, 2026approval127d agoIMATINIB MESYLATE — FDA approvalInhibikase Therapeutics, Inc.

    Sponsor: EUGIA PHARMA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 6, 2026approval
    ← prev
    page 1 of 15
    next →
    127d ago
    IMATINIB MESYLATE — FDA approvalInhibikase Therapeutics, Inc.

    Sponsor: EUGIA PHARMA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 6, 2026approval127d agoKEYTRUDA (PEMBROLIZUMAB) — FDA approvalpembrolizumab

    Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

    full page →pembrolizumab →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

    Sponsor: MICRO LABS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

    Sponsor: MICRO LABS. Form: TABLET. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

    Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

    Sponsor: BIOCON PHARMA. Form: TABLET. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

    Sponsor: MSN. Form: TABLET. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

    Sponsor: MSN. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

    Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE) — FDA approvalDAPAGLIFLOZIN

    Sponsor: AUROBINDO PHARMA. Form: TABLET

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalMicro Labs Ltd

    Sponsor: SUN PHARM. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN — FDA approvalMSN Pharmaceuticals Inc

    Sponsor: INVENTIA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

    Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN — FDA approvalMSN Pharmaceuticals Inc

    Sponsor: AIZANT. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 6, 2026approval127d agoKEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approval(berahyaluronidase alfa + pembrolizumab)

    Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION

    full page →(berahyaluronidase alfa + pembrolizumab) →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

    Sponsor: LUPIN LTD. Form: TABLET. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

    Sponsor: MSN. Form: TABLET. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

    Sponsor: CIPLA. Form: TABLET. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

    Sponsor: CIPLA LTD. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

    Sponsor: TORRENT. Form: TABLET. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN — FDA approvalMSN Pharmaceuticals Inc

    Sponsor: ALKEM LABS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

    Sponsor: MACLEODS PHARMS LTD. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

    Sponsor: ALEMBIC. Form: TABLET. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalMicro Labs Ltd

    Sponsor: ALKEM LABS LTD. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

    Sponsor: LUPIN LTD. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

    Sponsor: TEVA PHARMS USA INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

    Sponsor: CIPLA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval127d agoPAROXETINE HYDROCHLORIDE — FDA approvalPAROXETINE HYDROCHLORIDE

    Sponsor: AUROBINDO PHARMA USA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →PAROXETINE HYDROCHLORIDE →fda approvals ↗
    ›Apr 6, 2026approval127d agoPAROXETINE HYDROCHLORIDE — FDA approvalPAROXETINE HYDROCHLORIDE

    Sponsor: AUROBINDO PHARMA USA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →PAROXETINE HYDROCHLORIDE →fda approvals ↗
    ›Apr 6, 2026approval127d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

    Sponsor: SANDOZ. Form: TABLET. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval127d agoPAROXETINE HYDROCHLORIDE — FDA approvalPAROXETINE HYDROCHLORIDE

    Sponsor: AUROBINDO PHARMA USA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →PAROXETINE HYDROCHLORIDE →fda approvals ↗
    $IKT2.4600-0.40%
    $UTHR529.66-1.70%
    $RDHL0.7390+6.64%
    $REGN808.05+3.02%
    $DERM6.4400+0.16%
    $IKT2.4600-0.40%